Search

Reset

Searching with a thematic focus on HIV and AIDS treatment and care, HIV and AIDS

Showing 1121-1130 of 1199 results

Pages

  • Document

    Ageing in India

    Ageing and Life Course (WHO), 1999
    With no nation-wide registry of older people and community based data on morbidity not readily available, the absence of reliable and continuous sources of data on India makes the task of researchers difficult.Paper gives overview of issues of ageing population, coveringDemographic transition in IndiaDefining ageing in IndiaCurrent scenario and future projectionsAlso
  • Document

    Reality check: the need for deeper debt cancellation and the fight against HIV/AIDS

    Drop the Debt, 2001
    This article emphasises that the Heavily Indebted Poor Countries (HIPC) initiative fails to meet the challenge of significant debt cancellation. The article is critical on several counts.
  • Document

    What good can debt relief and PRSP do?: the case of Zambia

    Bread for the World, 2001
    This web resource looks into the Zambia's position of debt and the influence PRSPs and associated debt relief is having on Zambia.
  • Document

    Drug companies vs. Brazil: the threat to public health

    Oxfam, 2001
    The access of impoverished Brazilians to essential medicines, including those required for treatment of HIV/AIDS, is under threat.
  • Document

    WTO patent rules and access to medicines: the pressure mounts

    Oxfam, 2001
    Oxfam is calling for TRIPS to be reformed so that developing country governments have the unambiguous right to obtain the cheapest possible life-saving medicines without facing the threats of legal challenges or trade sanctions experienced by South Africa and Brazil.
  • Document

    World Trade Organisation agreements: implications for equity and health in Southern Africa

    EQUINET: Network for Equity in Health in Southern Africa, 2000
    This paper investigates the consequences of WTO agreements relating to health, and primarily the TRIPS agreement on health care and drug access for Southern African Development Community (SADC) countries.The paper provides a brief review of GATT /WTO and WTO agreements relating to health.
  • Document

    Communication from the European Communities and their Member States to the TRIPS council: the relationship between provisions of the TRIPS agreement and access to medicines

    European Union, 2001
    Paper comes in response to The EC and their Member States recognition of the lack of affordable pharmaceuticals as a serious problem in many developing countries and especially for the poorest people.Paper assesses: relevance of intellectual property; compulsory licensing; exceptions to patent rights; and, protection of undisclosed informationSummary and recommendations:The spirall
  • Document

    Encouragement of new clinical drug development: the role of data exclusivity

    International Federation of Pharmaceutical Manufacturers Associations, 2000
    Paper asserts that for the pharmaceutical industry to invest the billions of dollars, Euros, yen, etc. in these highly risky health care solutions, intellectual property protection is essential. However, patent and trade-mark protections are not the entire story.
  • Document

    Patent injustice: how world trade rules threaten the health of poor people

    Oxfam, 2001
    This briefing paper shows how new global patent rules, introduced by the World Trade Organisation, will raise the costs of vital medicines, with potentially disastrous implications for poor countries.
  • Document

    A patent policy proposal for global diseases

    Brookings Institution, 2001
    This policy brief outlines a proposal that would lower the price of pharmaceuticals that treat important global diseases in developing countries, while at the same time allowing patent protection to increase where it is most likely to lead to the creation of new products. The proposal requires no changes in international treaties, only minor changes to U.S.

Pages